Pricing Log in Create free account

iBio, Inc. (IBIO) vs Tevogen Inc. (TVGN)

iBio, Inc. and Tevogen Inc. are both Biotechnology companies. iBio, Inc. and Tevogen Inc. are of similar size ($47.6M and $46.1M). Across the 8 metrics below, iBio, Inc. leads on 5 and Tevogen Inc. on 3.

Valuation

Metric IBIO TVGN Biotechnology median
P/E n/m n/m 8.50
P/S 118.71 n/m 9.71
P/B 0.93 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.19 n/m 0.64
EV/Sales (9.70) n/m 9.21
Earnings yield (44.16%) (87.71%) (33.15%)
Free cash flow yield (30.24%) (42.97%) (25.50%)

Profitability

Metric IBIO TVGN Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.70%) 123.10% (56.36%)
Return on assets (54.04%) (492.20%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IBIO TVGN Biotechnology median
Revenue growth (TTM) (66.55%) — 6.02%
EPS growth (last fiscal year) 81.71% (72.66%) 30.26%
Revenue growth, 5-year CAGR (42.83%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IBIO TVGN Biotechnology median
Debt to equity 0.00 (0.72) 0.00
Current ratio 7.85 0.33 4.72
Net debt to EBITDA 2.57 (0.15) 0.96

Dividend

Metric IBIO TVGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IBIO TVGN Biotechnology median
Market cap 47.63m 46.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack